Literature DB >> 21673212

Vascular intervention for multiple sclerosis.

Michael Kolber1, Ken Makus, G Michael Allan, Noah Ivers.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21673212      PMCID： PMC3114668     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  13 in total

1.  Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study.

Authors:  Peter Sundström; Anders Wåhlin; Khalid Ambarki; Richard Birgander; Anders Eklund; Jan Malm
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

2.  Regression to the mean in multiple sclerosis.

Authors:  S Martínez-Yélamos; A Martínez-Yélamos; G Martín Ozaeta; V Casado; O Carmona; Tx Arbizu
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

3.  Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.

Authors:  R Zivadinov; K Marr; G Cutter; M Ramanathan; R H B Benedict; C Kennedy; M Elfadil; A E Yeh; J Reuther; C Brooks; K Hunt; M Andrews; E Carl; M G Dwyer; D Hojnacki; B Weinstock-Guttman
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

4.  No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset.

Authors:  Claudio Baracchini; Paola Perini; Massimiliano Calabrese; Francesco Causin; Francesca Rinaldi; Paolo Gallo
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

5.  Experimental multiple sclerosis vascular shunting procedure halted at Stanford.

Authors: 
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

6.  No cerebrocervical venous congestion in patients with multiple sclerosis.

Authors:  Florian Doepp; Friedemann Paul; José M Valdueza; Klaus Schmierer; Stephan J Schreiber
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

7.  Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

8.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

9.  Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.

Authors:  Yinshan Zhao; Anthony Traboulsee; A John Petkau; David Li
Journal:  Neurology       Date:  2007-11-14       Impact factor: 9.910

10.  Treatment of depression in people who have multiple sclerosis.

Authors:  A C Sollom; I I Kneebone
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.